This World Glaucoma Week we reflect on the ongoing relationship between City’s Crabb Lab and Glaucoma UK. Both share the goal of helping to end preventable sight loss caused by glaucoma.
It’s World Glaucoma Week, a unique initiative that puts a spotlight on glaucoma as the leading cause of preventable, irreversible blindness worldwide.
While over 700,000 people in the UK have glaucoma, with a large proportion of them not knowing they have the disease, prompt diagnosis and treatment of glaucoma can prevent the development of needless vision impairment in the community.
In January, City, University of London’s Crabb Lab team were delighted to welcome representatives from Glaucoma UK, the national charity which wants to end preventable sight loss caused by the disease. Representatives included Joanne Creighton, Chief Executive, and Natallie Hoare, Head of Fundraising at Glaucoma UK.
The meeting included updates on glaucoma research at the Crabb Lab, covering work funded by Glaucoma UK, and also a discussion around what the charity’s service users are sharing with them and what their current priorities are.
The goal of the Crabb Lab is to understand, diagnose and monitor eye disease in order to improve patient services and outcomes. The lab’s focus is on the measurement of vision to achieve its goal.
Glaucoma is a group of eye diseases which cause progressive damage to the optic nerve, and affects around 2% of people over 40 and almost 10% of those over 75, leading to more than a million hospital visits every year in the UK.
Once somebody loses sight through glaucoma it cannot be restored, so early detection and appropriate management is crucial.
David Crabb is Professor of Statistics and Vision Research at City and leads the Crabb Lab. He kicked off the meeting’s presentations with an overview of the lab’s glaucoma research and explained how funding from Glaucoma UK over the years has been invaluable in helping to make such progress possible.
Dr Peter Jones is a Lecturer in Optometry and Visual Science and a long term member of the Crabb Lab. His presentation went into more detail about current projects at the lab including work on Eyecatcher, a new way of testing vision in glaucoma.
Specialist optometrist and PhD student, Deborah Bott, supervised primarily by Dr Pete Campbell, Senior Lecturer in Optometry and Visual Science, then shared her presentation about her ongoing, glaucoma medication adherence project.
After a group discussion between all event participants, further presentations were delivered by Crabb Lab PhD students, Aiman Haifeez and Mehal Rathore.
Aiman shared her presentation about the effects of glaucoma on vision as part of her upcoming doctoral research.
Mehal shared her doctoral research into glaucoma diagnosis and deprivation.
Reflecting on the meeting during World Glaucoma Week, Joanne Creighton, Chief Executive at Glaucoma UK, said:
Natallie Hoare, Head of Fundraising at Glaucoma UK, said:
Professor David Crabb said: